Privi Speciality Chemicals schedules analyst meet on Aug 18

1 min read     Updated on 11 Aug 2026, 06:52 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Privi Speciality Chemicals Limited announced an analyst meet on August 18, 2026, in Mumbai, organized by MOSL. The session will include one-on-one and group discussions based on publicly available information, as per SEBI Regulation 30(6). No UPSI will be discussed.

powered bylight_fuzz_icon
48000120

*this image is generated using AI for illustrative purposes only.

Privi Speciality Chemicals Limited will host an analyst and institutional investor meeting on August 18, 2026, providing stakeholders with an opportunity to engage with company officials regarding business updates. The interaction is scheduled to begin at 09:00 AM IST in Mumbai and will be organized by MOSL, featuring both one-on-one and group meeting formats.

The company disclosed the schedule pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, submitting the intimation to both the Bombay Stock Exchange and the National Stock Exchange of India Ltd. This regulatory filing ensures transparency and allows investors to plan their participation in the upcoming engagement.

Meeting Details

Date & Time Nature of Meeting Organised by Place
August 18, 2026 1x1/ Group Meeting MOSL Mumbai

Company officials emphasized that all discussions during the conference will be restricted to publicly available information. Privi Speciality Chemicals explicitly stated that no unpublished price-sensitive information (UPSI) is intended to be discussed during these interactions, ensuring compliance with insider trading regulations.

Compliance and Governance

The announcement was signed by Ashwini Saumil Shah, Company Secretary & Compliance Officer, on August 11, 2026. The filing serves as a formal record for the exchanges and investors, noting that changes to the schedule may occur due to exigencies on the part of the host or the company.

This scheduled engagement aligns with standard corporate governance practices, allowing the management team to address market queries and share strategic insights within the bounds of regulatory disclosure norms. Investors are advised to monitor official communications for any last-minute changes to the venue or timing.

Historical Stock Returns for Privi Speciality Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.61%-3.95%-5.62%+22.48%+41.59%+110.71%

How might Privi Speciality Chemicals' recent capacity expansion projects influence the strategic updates presented at this August 2026 meeting?

What impact could current global supply chain dynamics in the specialty chemicals sector have on the company's guidance for the upcoming fiscal year?

Will management address any potential regulatory changes in key export markets that could affect Privi's long-term revenue projections?

Privi Speciality Chemicals
View Company Insights
View All News
like17
dislike

Privi Speciality Chemicals declares ₹10 dividend at AGM

2 min read     Updated on 07 Aug 2026, 09:33 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Privi Speciality Chemicals Limited concluded its 41st AGM on August 7, 2026, declaring a final dividend of ₹10 per share for FY26. Shareholders approved the re-appointment of Bhaktavatsala Rao Doppalapudi as Executive Director and ratified cost auditor fees. Statutory auditors B S R & Co., LLP issued a clean report.

powered bylight_fuzz_icon
47664224

*this image is generated using AI for illustrative purposes only.

Privi Speciality Chemicals Limited declared a final dividend of ₹10 per equity share for the financial year ended March 31, 2026, during its 41st Annual General Meeting (AGM) held on August 7, 2026. The speciality chemicals manufacturer convened the meeting through Video Conferencing and Other Audio-Visual Means to approve key corporate governance matters, including the re-appointment of senior leadership and the ratification of auditor fees. The dividend declaration represents a 100% payout relative to the face value of ₹10 per share, signaling management’s confidence in cash flows following the adoption of the audited standalone and consolidated financial statements.

The AGM, chaired by Chairman & Managing Director Mahesh Purshottam Babani, commenced at 4:00 p.m. IST and concluded at 4:58 p.m. IST. Sixty-one members participated in the virtual meeting. The Board sought shareholder approval for five resolutions, comprising ordinary business items such as the adoption of financials and director re-appointments, alongside special business regarding cost auditor remuneration and executive director appointments. All resolutions were placed before members in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key outcomes from the AGM include the re-appointment of Mahesh Purshottam Babani as a Director, who retired by rotation and offered himself for re-election. Additionally, shareholders approved the re-appointment of Bhaktavatsala Rao Doppalapudi as an Executive (Whole-time) Director for a period of three consecutive years, commencing August 13, 2026. The Board also secured approval to ratify the remuneration payable to Cost Auditors for the financial year ending March 31, 2027.

Resolution Type Description Outcome
Ordinary Adoption of Audited Financial Statements for FY26 Approved
Ordinary Declaration of Final Dividend of ₹10 per share Approved
Ordinary Re-appointment of Mahesh Purshottam Babani as Director Approved
Ordinary Ratification of Cost Auditor Remuneration for FY27 Approved
Special Re-appointment of Bhaktavatsala Rao Doppalapudi as Executive Director Approved

The statutory audit for FY26 was conducted by B S R & Co., LLP, while secretarial audit and scrutiny were handled by Rathi & Associates. Mr. Himanshu S. Kamdar, Partner at Rathi & Associates, served as the Scrutinizer for the e-voting process. The Statutory Auditor’s Report and Secretarial Auditor’s Report were taken as read, with no qualifications, observations, or adverse remarks noted by either auditor. This clean bill of health reinforces the company’s compliance posture under the Companies Act, 2013.

E-voting facilities were available to shareholders from 9:00 a.m. IST on August 4, 2026, until 5:00 p.m. IST on August 6, 2026, via MUFG Intime India Private Limited. Additional voting was permitted during the AGM and for 15 minutes post-conclusion to ensure maximum participation. The voting results will be communicated to BSE Limited and National Stock Exchange of India Limited within two working days of the meeting’s conclusion.

Governance Highlights

The meeting underscored Privi Speciality Chemicals’ adherence to regulatory frameworks, with the Company Secretary & Compliance Officer, Ashwini Saumil Shah, overseeing proceedings. The absence of physical attendance rendered proxy appointments unnecessary. Registers under Sections 170 and 189 of the Companies Act, 2013, were made available electronically for member inspection. The seamless execution of the virtual AGM reflects the company’s ongoing commitment to digital engagement and transparent corporate governance practices.

Historical Stock Returns for Privi Speciality Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+0.61%-3.95%-5.62%+22.48%+41.59%+110.71%

How might the re-appointment of Bhaktavatsala Rao Doppalapudi as Executive Director influence Privi Speciality Chemicals' strategic expansion plans for the next three years?

Given the 100% payout relative to face value, will this dividend policy remain sustainable if global speciality chemical demand fluctuates in FY27?

What specific growth initiatives or capital expenditures are likely to be prioritized by management following the approval of the audited financial statements?

Privi Speciality Chemicals
View Company Insights
View All News
like16
dislike

More News on Privi Speciality Chemicals

Must Read Next

Stocks

Denta Water to provide 6 tanks from Tungabhadra River for Mukkumpi Lift Irrigation Project 24 mins ago
no imag found
Coal India plans to bid for additional iron-ore blocks for pelletization plant 41 mins ago
Star Health Insurance anticipates home health care program to grow over 50% within a year 41 mins ago
1 Year Returns:+41.59%